A
AVEA
Science-Based Longevity supplements formulated in Switzerland to help people be as young as they feel
About AVEA
Avea Life is a health and wellness startup that operates in the burgeoning market of dietary supplements. The company's primary offering is a range of scientifically-formulated supplements designed to slow the signs of ageing, support natural collagen production, and optimize overall health. These products are targeted towards health-conscious consumers seeking to enhance their wellness and longevity.
The company's business model is straightforward. Customers visit the Avea Life website, take a simple quiz to determine their health needs, and are then recommended specific supplements that best fit their requirements. This personalized approach sets Avea Life apart in a crowded market, allowing them to cater to individual health needs rather than adopting a one-size-fits-all approach.
Avea Life's products are priced between £44.00 and £175.00, providing a range of options for different budgets. The company generates revenue through the direct sale of these supplements. The supplements have been approved by leading experts in the field, adding credibility to the brand and its offerings.
In terms of market, Avea Life operates in the global dietary supplements industry, which is expected to grow significantly due to increasing health awareness among consumers. The company's focus on anti-ageing and health optimization supplements positions it well to capitalize on this trend.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Zug, Switzerland
- Employees
- 58
- Open positions
- None listed
- Dealroom signal
- 84.7/100
- Industry
- Health, Wellness Beauty
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Dietary Supplements, Health and Wellness, Direct-to-Consumer, Sustainable Development Goals, Hard Tech, Woman Founder, Longevity, Food as Medicine, ogr torino
- Business model
- Manufacturing
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SUPPORT PROGRAM✓Other financing | Jan 2024 | $0 | — | Swissnex | — |
| SEEDEquity / VC | Nov 2023 | $1.8M | $7.3M | Maximon | — |
Growth signals
Latest recorded traffic for AVEA is 70K monthly website visits, down 41.7% over the last three months. AVEA's team grew 20.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Maximon
Other known investors1 additional known investor
Swissnex
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about AVEA on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See AVEA’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.